A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Retail & Omnichannel Market Intelligence Service.
FDA approves Amgen's Imdelltra as second or later line of treatment for advanced small-cell lung cancer patients; globally about 330,00 people are diagnosed with lung cancer every year, with about 35,000 patients living in the US
Published:
May 17, 2024
by Baystreet US News Alerts
|
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
Published:
May 17, 2024
by BioNTech SE
|
Australia Patent: F. HOFFMANN-LA ROCHE, GENENTECH File Application for 'METHODS FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE'
Published:
May 17, 2024
by Australian Government
|
Australia Patent: PFIZER Files Application for 'CDK4 INHIBITOR FOR THE TREATMENT OF CANCER'
Published:
May 17, 2024
by Australian Government
|
Australia Patent: AstraZeneca Files Application for 'METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES'
Published:
May 17, 2024
by Australian Government
|
Ask us about our Retail & Omnichannel market view